Pubchem Assays currently used (Total Number: 1345)

next

# Assay ID Assay Title Molecules Active
(Molecules Screened)
1 1 NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line 2124
(39103)
2 3 NCI human tumor cell line growth inhibition assay. Data for the NCI-H226 Non-Small Cell Lung cell line 1877
(35924)
3 5 NCI human tumor cell line growth inhibition assay. Data for the NCI-H322M Non-Small Cell Lung cell line 1602
(38199)
4 7 NCI human tumor cell line growth inhibition assay. Data for the NCI-H460 Non-Small Cell Lung cell line 2447
(37447)
5 9 NCI human tumor cell line growth inhibition assay. Data for the HOP-62 Non-Small Cell Lung cell line 1934
(38000)
6 11 NCI human tumor cell line growth inhibition assay. Data for the HOP-18 Non-Small Cell Lung cell line 614
(10377)
7 13 NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line 2007
(34054)
8 15 NCI human tumor cell line growth inhibition assay. Data for the NCI-H522 Non-Small Cell Lung cell line 2791
(34496)
9 17 NCI human tumor cell line growth inhibition assay. Data for the LXFL 529 Non-Small Cell Lung cell line 739
(12669)
10 19 NCI human tumor cell line growth inhibition assay. Data for the A549/ATCC Non-Small Cell Lung cell line 2047
(39451)
11 21 NCI human tumor cell line growth inhibition assay. Data for the EKVX Non-Small Cell Lung cell line 1501
(38679)
12 23 NCI human tumor cell line growth inhibition assay. Data for the LOX IMVI Melanoma cell line 2571
(35928)
13 25 NCI human tumor cell line growth inhibition assay. Data for the M14 Melanoma cell line 2017
(38492)
14 27 NCI human tumor cell line growth inhibition assay. Data for the M19-MEL Melanoma cell line 815
(13766)
15 29 NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line 2032
(36343)
16 31 NCI human tumor cell line growth inhibition assay. Data for the UACC-62 Melanoma cell line 2217
(38069)
17 33 NCI human tumor cell line growth inhibition assay. Data for the UACC-257 Melanoma cell line 1710
(39163)
18 35 NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-2 Melanoma cell line 1659
(36820)
19 37 NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line 2280
(37986)
20 39 NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-28 Melanoma cell line 1509
(39048)
21 41 NCI human tumor cell line growth inhibition assay. Data for the PC-3 Prostate cell line 1642
(26558)
22 43 NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line 1553
(26531)
23 45 NCI human tumor cell line growth inhibition assay. Data for the SF-268 Central Nervous System cell line 2081
(38638)
24 47 NCI human tumor cell line growth inhibition assay. Data for the SF-295 Central Nervous System cell line 2103
(39046)
25 49 NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line 2148
(36319)
26 51 NCI human tumor cell line growth inhibition assay. Data for the XF 498 Central Nervous System cell line 798
(10984)
27 53 NCI human tumor cell line growth inhibition assay. Data for the SNB-19 Central Nervous System cell line 1758
(38928)
28 55 NCI human tumor cell line growth inhibition assay. Data for the SNB-75 Central Nervous System cell line 2126
(35978)
29 57 NCI human tumor cell line growth inhibition assay. Data for the SNB-78 Central Nervous System cell line 604
(12798)
30 59 NCI human tumor cell line growth inhibition assay. Data for the U251 Central Nervous System cell line 2247
(38955)
31 61 NCI human tumor cell line growth inhibition assay. Data for the DMS 273 Small Cell Lung cell line 920
(12300)
32 63 NCI human tumor cell line growth inhibition assay. Data for the DMS 114 Small Cell Lung cell line 962
(13345)
33 65 NCI human tumor cell line growth inhibition assay. Data for the HT29 Colon cell line 2193
(38919)
34 67 NCI human tumor cell line growth inhibition assay. Data for the COLO 205 Colon cell line 2194
(38609)
35 69 NCI human tumor cell line growth inhibition assay. Data for the DLD-1 Colon cell line 787
(13266)
36 71 NCI human tumor cell line growth inhibition assay. Data for the HCT-15 Colon cell line 2168
(38663)
37 73 NCI human tumor cell line growth inhibition assay. Data for the KM12 Colon cell line 2074
(38851)
38 75 NCI human tumor cell line growth inhibition assay. Data for the KM20L2 Colon cell line 710
(13022)
39 77 NCI human tumor cell line growth inhibition assay. Data for the HCC-2998 Colon cell line 1882
(34881)
40 79 NCI human tumor cell line growth inhibition assay. Data for the HCT-116 Colon cell line 2565
(38328)
41 81 NCI human tumor cell line growth inhibition assay. Data for the SW-620 Colon cell line 2497
(38924)
42 83 NCI human tumor cell line growth inhibition assay. Data for the MCF7 Breast cell line 2381
(26079)
43 85 NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-435 Breast cell line 1883
(26378)
44 87 NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line 1837
(25839)
45 89 NCI human tumor cell line growth inhibition assay. Data for the BT-549 Breast cell line 1296
(23916)
46 91 NCI human tumor cell line growth inhibition assay. Data for the T-47D Breast cell line 1571
(24901)
47 93 NCI human tumor cell line growth inhibition assay. Data for the NCI/ADR-RES Breast cell line 1486
(27059)
48 95 NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-231/ATCC Breast cell line 1468
(26243)
49 97 NCI human tumor cell line growth inhibition assay. Data for the HS 578T Breast cell line 1478
(24944)
50 99 NCI human tumor cell line growth inhibition assay. Data for the OVCAR-3 Ovarian cell line 2171
(37782)
51 101 NCI human tumor cell line growth inhibition assay. Data for the IGROV1 Ovarian cell line 2110
(38684)
52 103 NCI human tumor cell line growth inhibition assay. Data for the SK-OV-3 Ovarian cell line 1587
(37373)
53 105 NCI human tumor cell line growth inhibition assay. Data for the OVCAR-4 Ovarian cell line 1581
(37559)
54 107 NCI human tumor cell line growth inhibition assay. Data for the OVCAR-5 Ovarian cell line 1357
(38818)
55 109 NCI human tumor cell line growth inhibition assay. Data for the OVCAR-8 Ovarian cell line 2154
(39245)
56 111 NCI human tumor cell line growth inhibition assay. Data for the P388 Leukemia cell line 355
(664)
57 113 NCI human tumor cell line growth inhibition assay. Data for the RPMI-8226 Leukemia cell line 2789
(35357)
58 115 NCI human tumor cell line growth inhibition assay. Data for the SR Leukemia cell line 3367
(30396)
59 117 NCI human tumor cell line growth inhibition assay. Data for the P388/ADR Leukemia cell line 265
(731)
60 119 NCI human tumor cell line growth inhibition assay. Data for the CCRF-CEM Leukemia cell line 3631
(35590)
61 121 NCI human tumor cell line growth inhibition assay. Data for the K-562 Leukemia cell line 3001
(37290)
62 123 NCI human tumor cell line growth inhibition assay. Data for the MOLT-4 Leukemia cell line 3236
(37387)
63 125 NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line 3438
(33901)
64 127 NCI human tumor cell line growth inhibition assay. Data for the SN12K1 Renal cell line 270
(765)
65 129 NCI human tumor cell line growth inhibition assay. Data for the A498 Renal cell line 1679
(33766)
66 131 NCI human tumor cell line growth inhibition assay. Data for the CAKI-1 Renal cell line 2129
(36269)
67 133 NCI human tumor cell line growth inhibition assay. Data for the RXF 393 Renal cell line 2086
(34445)
68 135 NCI human tumor cell line growth inhibition assay. Data for the RXF-631 Renal cell line 507
(10293)
69 137 NCI human tumor cell line growth inhibition assay. Data for the 786-0 Renal cell line 2174
(38180)
70 139 NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line 2093
(38519)
71 141 NCI human tumor cell line growth inhibition assay. Data for the TK-10 Renal cell line 1333
(38603)
72 143 NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line 1944
(38578)
73 145 NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line 2029
(38851)
74 147 NCI Yeast Anticancer Drug Screen. Data for the rad52 strain 1112
(610)
75 149 NCI Yeast Anticancer Drug Screen. Data for the wt1 strain 811
(911)
76 151 NCI Yeast Anticancer Drug Screen. Data for the rad50EPP+ strain 769
(953)
77 153 NCI Yeast Anticancer Drug Screen. Data for the mgt1 strain 989
(733)
78 155 NCI Yeast Anticancer Drug Screen. Data for the rad50 strain 9907
(72610)
79 157 NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain 8920
(73597)
80 159 NCI Yeast Anticancer Drug Screen. Data for the rad14 strain 1004
(718)
81 161 NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain 9646
(72210)
82 163 NCI Yeast Anticancer Drug Screen. Data for the CLN2oe strain 845
(877)
83 165 NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain 8161
(73695)
84 167 NCI Yeast Anticancer Drug Screen. Data for the bub3 strain 9708
(72154)
85 169 NCI Yeast Anticancer Drug Screen. Data for the wt2 strain 1003
(747)
86 171 NCI Yeast Anticancer Drug Screen. Data for the mlh1 strain 1006
(716)
87 173 NCI Yeast Anticancer Drug Screen. Data for the sgs1 strain 1096
(626)
88 175 NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain 10273
(72222)
89 177 NCI Yeast Anticancer Drug Screen. Data for the rad18 strain 1103
(619)
90 179 NCI AIDS Antiviral Assay 1549
(40601)
91 192 NCI In Vivo Anticancer Drug Screen. Data for tumor model B16 Melanoma (intraperitoneal) in B6D2F1 (BDF1) mice 500
(4708)
92 200 NCI In Vivo Anticancer Drug Screen. Data for tumor model B16 Melanoma (intraperitoneal) in B6C3F1 mice 346
(1125)
93 206 NCI In Vivo Anticancer Drug Screen. Data for tumor model HT29 186
(566)
94 212 NCI In Vivo Anticancer Drug Screen. Data for tumor model Colon Carcinoma 38 (subcutaneous) in B6D2F1 (BDF1) mice 308
(502)
95 220 NCI In Vivo Anticancer Drug Screen. Data for tumor model Mammary Adenocarcinoma CD8F1 (subcutaneous) in CD8F1 291
(614)
96 248 NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice 1602
(53818)
97 250 NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (subcutaneous) in B6D2F1 (BDF1) mice 131
(187)
98 256 NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice 1040
(18275)
99 264 NCI In Vivo Anticancer Drug Screen. Data for tumor model Human Lung LX-1 Xenograft (intrarenal inoculation) in NU/NU Swiss (nude) mice 156
(589)
100 270 NCI In Vivo Anticancer Drug Screen. Data for tumor model Lewis Lung Carcinoma (subcutaneous) in B6D2F1 (BDF1) mice 105
(672)
101 292 NCI In Vivo Anticancer Drug Screen. Data for tumor model Sarcoma M5076 (intraperitoneal) in B6C3F1 mice 129
(583)

next